Amgen (AMGN) Tops Q2 Earnings and Revenue Estimates

Amgen (AMGN) came out with quarterly earnings of $4.25 per share, beating the Zacks Consensus Estimate of $3.81 per share. This compares to earnings of $3.97 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 11.55%. A quarter ago, it was expected that this world's largest biotech drugmaker would post earnings of $3.70 per share when it actually produced earnings of $4.17, delivering a surprise of 12.70%.